{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:45:08Z","timestamp":1771235108613,"version":"3.50.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ccl.2020.07.009","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T06:44:22Z","timestamp":1600325062000},"page":"629-637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Refractory Angina\u2014Unsolved Problem"],"prefix":"10.1016","volume":"38","author":[{"given":"Marcin","family":"Makowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna Samanta","family":"Makowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzenna","family":"Zieli\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ccl.2020.07.009_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/euhj.2001.2706","article-title":"The problem of chronic refractory angina; report from the ESC Joint study group on the treatment of refractory angina","volume":"23","author":"Mannheimer","year":"2002","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ccl.2020.07.009_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ijcard.2009.09.538","article-title":"Fatality, morbidity and quality of life in patients with refractory angina pectoris","volume":"147","author":"Andrell","year":"2011","journal-title":"Int J Cardiol"},{"issue":"14","key":"10.1016\/j.ccl.2020.07.009_bib3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199909303411403","article-title":"Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina","volume":"341","author":"Allen","year":"1999","journal-title":"N Engl J Med"},{"issue":"9182","key":"10.1016\/j.ccl.2020.07.009_bib4","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0140-6736(99)08113-1","article-title":"Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison","volume":"354","author":"Burkhoff","year":"1999","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ccl.2020.07.009_bib5","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199909303411402","article-title":"Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease","volume":"341","author":"Frazier","year":"1999","journal-title":"N Engl J Med"},{"issue":"9243","key":"10.1016\/j.ccl.2020.07.009_bib6","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(00)03203-7","article-title":"Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement from Intramyocardial Channels","volume":"356","author":"Oesterle","year":"2000","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ccl.2020.07.009_bib7","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jacc.2007.06.010","article-title":"Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials","volume":"50","author":"Henry","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ccl.2020.07.009_bib8","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2004.12.068","article-title":"Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial","volume":"45","author":"Kastrup","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"34","key":"10.1016\/j.ccl.2020.07.009_bib9","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/eurheartj\/eht165","article-title":"Long-term survival in patients with refractory angina","volume":"34","author":"Henry","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccl.2020.07.009_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-3-540-79090-7_6","article-title":"Regulation of cardiac afferent excitability in ischemia","volume":"194","author":"Fu","year":"2009","journal-title":"Handb Exp Pharmacol"},{"issue":"13","key":"10.1016\/j.ccl.2020.07.009_bib11","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.CIR.0000142618.20278.7A","article-title":"Sensing tissue ischemia: another new function for capsaicin receptors?","volume":"110","author":"Pan","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccl.2020.07.009_bib12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0735-1097(94)90306-9","article-title":"Substance P potentiates the algogenic effects of intraarterial infusion of adenosine","volume":"24","author":"Gaspardone","year":"1994","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2020.07.009_bib13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/j.2040-4603.2015.tb00616.x","article-title":"Mechanisms of cardiac pain","volume":"5","author":"Foreman","year":"2015","journal-title":"Compr Physiol"},{"issue":"10","key":"10.1016\/j.ccl.2020.07.009_bib14","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jacc.2018.12.064","article-title":"Autonomic nervous system dysfunction: JACC focus seminar","volume":"73","author":"Goldberger","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"8916","key":"10.1016\/j.ccl.2020.07.009_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(94)92755-3","article-title":"Central nervous pathways mediating angina pectoris","volume":"344","author":"Rosen","year":"1994","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ccl.2020.07.009_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/07853890008995938","article-title":"The brain-heart axis in the perception of cardiac pain: the elusive link between ischaemia and pain","volume":"32","author":"Rosen","year":"2000","journal-title":"Ann Med"},{"issue":"13","key":"10.1016\/j.ccl.2020.07.009_bib17","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0002-9149(91)90868-L","article-title":"Detection of silent myocardial ischemia in diabetes mellitus","volume":"67","author":"Langer","year":"1991","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2020.07.009_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/hrt.71.1.22","article-title":"Differences in autonomic nerve function in patients with silent and symptomatic myocardial ischaemia","volume":"71","author":"Shakespeare","year":"1994","journal-title":"Br Heart J"},{"issue":"5","key":"10.1016\/j.ccl.2020.07.009_bib19","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1161\/01.CIR.89.5.1958","article-title":"Is 'silent' myocardial ischemia really as severe as symptomatic ischemia? The analytical effect of patient selection biases","volume":"89","author":"Klein","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2020.07.009_bib20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ijcard.2015.08.045","article-title":"Unresolved issues in the management of chronic stable angina","volume":"201","author":"Camm","year":"2015","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2020.07.009_bib21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nrcardio.2017.131","article-title":"Expert consensus document: a 'diamond' approach to personalized treatment of angina","volume":"15","author":"Ferrari","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2020.07.009_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.ccl.2020.07.009_bib23","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"Fihn","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2020.07.009_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"Mega","year":"2012","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.ccl.2020.07.009_bib25","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.jacc.2016.03.529","article-title":"Reduction in ischemic events with ticagrelor in diabetic patients with prior myocardial infarction in PEGASUS-TIMI 54","volume":"67","author":"Bhatt","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2020.07.009_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jacc.2017.11.050","article-title":"Ticagrelor for secondary prevention of atherothrombotic events in patients with multivessel coronary disease","volume":"71","author":"Bansilal","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.ccl.2020.07.009_bib27","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.jacc.2016.03.524","article-title":"Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease","volume":"67","author":"Bonaca","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2020.07.009_bib28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s40521-015-0049-x","article-title":"NSAIDs hypersensitivity: when and how to desensitize?","volume":"2","author":"Makowska","year":"2015","journal-title":"Curr Treat Options Allergy"},{"issue":"9732","key":"10.1016\/j.ccl.2020.07.009_bib29","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(10)60391-1","article-title":"Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial","volume":"375","author":"Noman","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ccl.2020.07.009_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13075-016-1111-1","article-title":"Allopurinol reduces the risk of myocardial infarction (MI) in the elderly: a study of Medicare claims","volume":"18","author":"Singh","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.ccl.2020.07.009_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000112412","article-title":"The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction - baseline characteristics of the study population","volume":"110","author":"Beautiful Study","year":"2008","journal-title":"Cardiology"},{"issue":"38","key":"10.1016\/j.ccl.2020.07.009_bib32","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"Suppl 3","key":"10.1016\/j.ccl.2020.07.009_bib33","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1097\/00005344-199206203-00010","article-title":"Acute hemodynamic effects of nicorandil in coronary artery disease","volume":"20","author":"Treese","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"issue":"9314","key":"10.1016\/j.ccl.2020.07.009_bib34","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(02)08265-X","article-title":"Effect of nicorandil on coronary events in patients with stable angina: the Impact of Nicorandil in Angina (IONA) randomised trial","volume":"359","author":"Group","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ccl.2020.07.009_bib35","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/eurheartj\/ehn571","article-title":"Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial","volume":"30","author":"Tardif","year":"2009","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.ccl.2020.07.009_bib36","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/eurheartj\/ehi586","article-title":"Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina","volume":"26","author":"Tardif","year":"2005","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ccl.2020.07.009_bib37","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.0000139333.83620.5D","article-title":"Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties","volume":"110","author":"Antzelevitch","year":"2004","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ccl.2020.07.009_bib38","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","article-title":"Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina","volume":"43","author":"Chaitman","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2020.07.009_bib39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ccl.2020.07.009_bib40","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial","volume":"48","author":"Stone","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ccl.2020.07.009_bib41","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jacc.2010.04.042","article-title":"The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease","volume":"56","author":"Stone","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2020.07.009_bib42","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1161\/01.RES.0000086943.72932.71","article-title":"The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase","volume":"93","author":"MacInnes","year":"2003","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.ccl.2020.07.009_bib43","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.86.5.580","article-title":"The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase","volume":"86","author":"Kantor","year":"2000","journal-title":"Circ Res"},{"issue":"24","key":"10.1016\/j.ccl.2020.07.009_bib44","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1053\/euhj.2001.2896","article-title":"Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand","volume":"22","author":"Szwed","year":"2001","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ccl.2020.07.009_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003614.pub2","article-title":"Trimetazidine for stable angina","author":"Ciapponi","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ccl.2020.07.009_bib46","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1017\/S0033291796004382","article-title":"A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects","volume":"27","author":"Spinhoven","year":"1997","journal-title":"Psychol Med"},{"issue":"5","key":"10.1016\/j.ccl.2020.07.009_bib47","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0022-3999(94)90102-3","article-title":"Chest pain self-management training for patients with coronary artery disease","volume":"38","author":"Payne","year":"1994","journal-title":"J Psychosom Res"},{"issue":"2","key":"10.1016\/j.ccl.2020.07.009_bib48","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/01.CIR.80.2.234","article-title":"An overview of randomized trials of rehabilitation with exercise after myocardial infarction","volume":"80","author":"O'Connor","year":"1989","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ccl.2020.07.009_bib49","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.CIR.99.6.779","article-title":"Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study","volume":"99","author":"de Lorgeril","year":"1999","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccl.2020.07.009_bib50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00000441-199905000-00005","article-title":"The exercise-induced oxidative stress paradox: the effects of physical exercise training","volume":"317","author":"Leaf","year":"1999","journal-title":"Am J Med Sci"},{"issue":"23","key":"10.1016\/j.ccl.2020.07.009_bib51","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1056\/NEJM199312023292301","article-title":"Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators","volume":"329","author":"Mittleman","year":"1993","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ccl.2020.07.009_bib52","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/hrt.82.6.654","article-title":"Improving quality of life in patients with angina","volume":"82","author":"Lewin","year":"1999","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.ccl.2020.07.009_bib53","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/heart.89.8.830","article-title":"Enhanced external counterpulsation for refractory angina pectoris","volume":"89","author":"Sinvhal","year":"2003","journal-title":"Heart"},{"issue":"11","key":"10.1016\/j.ccl.2020.07.009_bib54","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ncpcardio0691","article-title":"Primer: practical approach to the selection of patients for and application of EECP","volume":"3","author":"Michaels","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.ccl.2020.07.009_bib55","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijcard.2010.08.020","article-title":"Effect of enhanced external counterpulsation on circulating CD34+ progenitor cell subsets","volume":"153","author":"Kiernan","year":"2011","journal-title":"Int J Cardiol"},{"issue":"16","key":"10.1016\/j.ccl.2020.07.009_bib56","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.109.923482","article-title":"Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study","volume":"122","author":"Braith","year":"2010","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ccl.2020.07.009_bib57","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0735-1097(03)00329-2","article-title":"Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease","volume":"41","author":"Bonetti","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2020.07.009_bib58","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ahj.2005.01.054","article-title":"The effects of enhanced external counterpulsation on myocardial perfusion in patients with stable angina: a multicenter radionuclide study","volume":"150","author":"Michaels","year":"2005","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ccl.2020.07.009_bib59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.amjcard.2006.01.053","article-title":"Effect of external counterpulsation on plasma nitric oxide and endothelin-1 levels","volume":"98","author":"Akhtar","year":"2006","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2020.07.009_bib60","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.ahj.2008.07.024","article-title":"Enhanced external counterpulsation improves systolic blood pressure in patients with refractory angina","volume":"156","author":"Campbell","year":"2008","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.ccl.2020.07.009_bib61","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0735-1097(99)00140-0","article-title":"The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes","volume":"33","author":"Arora","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.ccl.2020.07.009_bib62","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1161\/CIRCULATIONAHA.106.628623","article-title":"Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia","volume":"114","author":"Aicher","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccl.2020.07.009_bib63","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.niox.2004.12.005","article-title":"Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO production","volume":"12","author":"Mariotto","year":"2005","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ccl.2020.07.009_bib64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1476-7120-10-35","article-title":"A modified regimen of extracorporeal cardiac shock wave therapy for treatment of coronary artery disease","volume":"10","author":"Wang","year":"2012","journal-title":"Cardiovasc Ultrasound"},{"issue":"15","key":"10.1016\/j.ccl.2020.07.009_bib65","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/jama.2013.3527","article-title":"Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial","volume":"309","author":"Assmus","year":"2013","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ccl.2020.07.009_bib66","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0002-9149(97)89338-1","article-title":"Effect of spinal cord stimulation on myocardial blood flow assessed by positron emission tomography in patients with refractory angina pectoris","volume":"77","author":"Hautvast","year":"1996","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2020.07.009_bib67","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/hrt.71.5.413","article-title":"Effects of spinal cord stimulation on myocardial ischaemia during daily life in patients with severe coronary artery disease. A prospective ambulatory electrocardiographic study","volume":"71","author":"de Jongste","year":"1994","journal-title":"Br Heart J"},{"issue":"8","key":"10.1016\/j.ccl.2020.07.009_bib68","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/j.1526-4637.2010.00915.x","article-title":"What does the mechanism of spinal cord stimulation tell us about complex regional pain syndrome?","volume":"11","author":"Prager","year":"2010","journal-title":"Pain Med"},{"issue":"14","key":"10.1016\/j.ccl.2020.07.009_bib69","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/hrt.2009.177188","article-title":"Long-term effects of spinal cord stimulation on angina symptoms and quality of life in patients with refractory angina pectoris--results from the European Angina Registry Link Study (EARL)","volume":"96","author":"Andrell","year":"2010","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.ccl.2020.07.009_bib70","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/hrt.2006.100784","article-title":"Thoracic spinal cord stimulation improves functional status and relieves symptoms in patients with refractory angina pectoris: the first placebo-controlled randomised study","volume":"93","author":"Eddicks","year":"2007","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ccl.2020.07.009_bib71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pain.2010.08.044","article-title":"Spinal cord stimulation for the treatment of refractory angina pectoris: a multicenter randomized single-blind study (the SCS-ITA trial)","volume":"152","author":"Lanza","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.ccl.2020.07.009_bib72","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1525-1403.2012.00452.x","article-title":"Spinal cord stimulation therapy for patients with refractory angina who are not candidates for revascularization","volume":"15","author":"Zipes","year":"2012","journal-title":"Neuromodulation"},{"issue":"3","key":"10.1016\/j.ccl.2020.07.009_bib73","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1525-1403.2011.00355.x","article-title":"Subcutaneous electrical nerve stimulation: a feasible and new method for the treatment of patients with refractory angina","volume":"14","author":"Buiten","year":"2011","journal-title":"Neuromodulation"},{"issue":"6","key":"10.1016\/j.ccl.2020.07.009_bib74","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1177\/096721099600400629","article-title":"Angina pectoris treated by thoracoscopic sympathecotomy","volume":"4","author":"Claes","year":"1996","journal-title":"Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.ccl.2020.07.009_bib75","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0002-8703(97)70166-2","article-title":"Treatment of medically and surgically refractory angina pectoris with high thoracic epidural analgesia: initial clinical experience","volume":"133","author":"Gramling-Babb","year":"1997","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.ccl.2020.07.009_bib76","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/jama.1948.02890390014003","article-title":"Revascularization of heart by graft of systemic artery into coronary sinus","volume":"137","author":"Beck","year":"1948","journal-title":"J Am Med Assoc"},{"issue":"17","key":"10.1016\/j.ccl.2020.07.009_bib77","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.jacc.2007.01.061","article-title":"Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study","volume":"49","author":"Banai","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ccl.2020.07.009_bib78","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.4244\/EIJV9I10A196","article-title":"Transcatheter treatment for refractory angina with the coronary sinus reducer","volume":"9","author":"Konigstein","year":"2014","journal-title":"EuroIntervention"},{"issue":"8","key":"10.1016\/j.ccl.2020.07.009_bib79","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","article-title":"Coronary microvascular dysfunction","volume":"356","author":"Camici","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ccl.2020.07.009_bib80","doi-asserted-by":"crossref","first-page":"H1361","DOI":"10.1152\/ajpheart.2001.280.3.H1361","article-title":"Coronary sinus occlusion enhances coronary collateral flow and reduces subendocardial ischemia","volume":"280","author":"Ido","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10.1016\/j.ccl.2020.07.009_bib81","first-page":"E3","article-title":"Mild increase in coronary sinus pressure with coronary sinus reducer stent for treatment of refractory angina","volume":"6","author":"Paz","year":"2009","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.ccl.2020.07.009_bib82","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.jtcvs.2004.01.036","article-title":"The salvage potential of coronary sinus interventions: meta-analysis and pathophysiologic consequences","volume":"127","author":"Syeda","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.ccl.2020.07.009_bib83","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1510\/icvts.2004.095364","article-title":"Intermittent pressure elevation of the coronary venous system as a method to protect ischemic myocardium","volume":"4","author":"Mohl","year":"2005","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"6","key":"10.1016\/j.ccl.2020.07.009_bib84","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJMoa1402556","article-title":"Efficacy of a device to narrow the coronary sinus in refractory angina","volume":"372","author":"Verheye","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2020.07.009_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2020.03.042","article-title":"Efficacy of coronary sinus reducer in patients with non-revascularized chronic total occlusions","volume":"126","author":"Zivelonghi","year":"2020","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2020.07.009_bib86","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/01.CIR.77.6.1403","article-title":"Effect of pressure-controlled intermittent coronary sinus occlusion on pacing-induced myocardial ischemia in domestic swine","volume":"77","author":"Fedele","year":"1988","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccl.2020.07.009_bib87","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/01.CIR.76.3.667","article-title":"The efficacy of intermittent coronary sinus occlusion in the absence of coronary artery collaterals","volume":"76","author":"Toggart","year":"1987","journal-title":"Circulation"},{"issue":"33","key":"10.1016\/j.ccl.2020.07.009_bib88","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1093\/eurheartj\/ehx352","article-title":"Adenoviral intramyocardial VEGF-DDeltaNDeltaC gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I\/IIa study with 1-year follow-up","volume":"38","author":"Hartikainen","year":"2017","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.ccl.2020.07.009_bib89","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/eurheartj\/ehx764","article-title":"Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials","volume":"39","author":"Henry","year":"2018","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ccl.2020.07.009_bib90","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3727\/096368916X691484","article-title":"Autologous CD34(+) Cell therapy for refractory angina: 2-year outcomes from the ACT34-CMI study","volume":"25","author":"Henry","year":"2016","journal-title":"Cell Transplant"},{"issue":"5","key":"10.1016\/j.ccl.2020.07.009_bib91","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1097\/CCM.0000000000003051","article-title":"The five-year clinical and angiographic follow-up outcomes of intracoronary transfusion of circulation-derived CD34+ cells for patients with end-stage diffuse coronary artery disease unsuitable for coronary intervention-phase i clinical trial","volume":"46","author":"Sung","year":"2018","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1016\/j.ccl.2020.07.009_bib92","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/CIRCRESAHA.115.303463","article-title":"Selected CD133(+) progenitor cells to promote angiogenesis in patients with refractory angina: final results of the PROGENITOR randomized trial","volume":"115","author":"Jimenez-Quevedo","year":"2014","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.ccl.2020.07.009_bib93","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/CIRCRESAHA.116.309009","article-title":"Effects of transendocardial delivery of bone marrow-derived CD133(+) cells on left ventricle perfusion and function in patients with refractory angina: final results of randomized, double-blinded, placebo-controlled REGENT-VSEL trial","volume":"120","author":"Wojakowski","year":"2017","journal-title":"Circ Res"},{"issue":"15","key":"10.1016\/j.ccl.2020.07.009_bib94","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jcin.2016.05.003","article-title":"The RENEW trial: efficacy and safety of intramyocardial autologous CD34(+) cell administration in patients with refractory angina","volume":"9","author":"Povsic","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.ccl.2020.07.009_bib95","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/01.CIR.100.5.468","article-title":"Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease","volume":"100","author":"Rosengart","year":"1999","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.ccl.2020.07.009_bib96","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/01.CIR.103.17.2138","article-title":"Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia","volume":"103","author":"Vale","year":"2001","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccl.2020.07.009_bib97","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/hrt.2009.185769","article-title":"NICE evaluation of transmyocardial laser revascularisation and percutaneous laser revascularisation for refractory angina","volume":"96","author":"Schofield","year":"2010","journal-title":"Heart"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865120300655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865120300655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:53:52Z","timestamp":1760007232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865120300655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":97,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0733865120300655"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2020.07.009","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refractory Angina\u2014Unsolved Problem","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2020.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}